April 10, 2021
Our Stand on Technological Sovereignty
adVentures' founder, Antoine Duboscq, brings forward in an opinion piece in "Le Figaro", a geopolitical…
April 2, 2021
GEG-Tech raises 1M€ from Private Investors
Our genetic engineering biotech closed a fundraising of 1M€ from private investors. GEG-Tech is a…
August 19, 2020
GEG-TECH publishes on the scientific journal “FORTUNE JOURNAL”
We would like to congratulate Léa Monet and Nicolas Granchamp for their article on "The…
April 17, 2020
Our COVID-19 Crisis Related Initiatives
Discover how our portfolio companies are contributing in the times of the COVID-19 crisis.
March 3, 2020
GEG-Tech Signs Distribution Agreement with Tebu-Bio
GEG-tech’s agreement with tebu-bio expands the distribution of advanced vectorisation systems & tools, designed by…
January 11, 2018
First-ever live tracking of HIV-1 vectors
This technology breakthrough obtained by NeoVirTech and GEG Tech allows the visualization of lentivirus genomes…
December 18, 2017
GEG-Tech positions an offer on CAR T-Cells
GEG-Tech, adVentures Studio's Genetic Engineering Firm, has positioned an offer in CAR T-cell Therapy (Cancer…